FDA sets new deadline for Pfizer, BMS clotting drug; Dr Reddy's launches generic Singulair product;

@FiercePharma: Deadbeat European states owe pharma between £9.5B and £12B, new report finds. More | Follow @FiercePharma

> FDA will pass judgment on Pfizer ($PFE) and Bristol-Myers Squibb's ($BMY) clot-fighting drug Eliquis by mid-March, after asking for more information earlier this year. Report

> Dr. Reddy's Laboratories launched its generic Singulair oral granules in the U.S. Report

> Mylan Specialty hired Julie Bowen, an actress on Modern Family, for a campaign designed to draw attention to severe allergic reactions. Report

> China is experimenting with doctor-payment reforms to satisfy patients and curb healthcare-related violence. Report

> Germany's top mail-order pharmacy, Sanicare, filed for insolvency in the wake of the death of its founder Johannes Moenter; it will be run by a court-appointed administrator. Report

> Restrictions on opioid painkillers are making it tough for some pain patients to obtain their medications. Report

> Analysts upgraded their outlook on Shire ($SHPG) after a legal settlement with rivals for its ADHD drugs. Report

Medical Device News

 @FierceMedDev: Second Sight's Argus II retinal prosthesis will go before an FDA panel tomorrow. More | Follow @FierceMedDev

 @MarkHFierce: Who makes the most among the leaders of the top 20 research institutes? More | Follow @MarkHFierce

 @DamianFierce: With devicemakers big and small angling to cash in on renal denervation, we take a closer look at five hyped-up techs. More | Follow @DamianFierce

> Heart valve device sales are booming in Europe. Item

> IlluminOss snags $28M for bone-repair tech. Article

> NanoString's gene expression breast cancer Dx gains CE mark. Story

Biotech News

 @FierceBiotech: Check out our report on 10 next-gen biotech drug techs and the pharma's betting on them. More | Follow @FierceBiotech

 @JohnCFierce: Want to reduce the drug spend? Cut the price, by fiat. India designates 348 drugs "essential." More | Follow @JohnCFierce

 @RyanMFierce: My article on genomics outfit Knome, putting genetic tests on computers. More | Follow @RyanMFierce

> Achillion heralds upbeat hepatitis C results as it rushes through Phase II. Story

> Biotech stars make WSJ's list of top startups as healthcare lags. Report

> Science advisors lay out ambitious plan to double FDA approval rates. Article

Pharma Manufacturing News

@EricPFierce: Check it out: The 20 top-selling vaccines in H1 2012. Vax market now $27B, total. Special Report | Follow @EricPFierce

> API maker says more clients looking for U.S. manufacturers. Story

> New FDA hand-held scanner sheds light on counterfeits. Article

Vaccines News

@AlisonBFierce: HIV vaccine trials labor to enroll women. | Follow @AlisonBFierce

> Medicago, Philip Morris ink China vaccines deal. Article

> Atreca lands $6M for vaccine research. Item

> Johns Hopkins doles out pneumonia prevention grants. Report

> PsiOxus launches human tests of cancer vaccine. Story

And Finally... Researchers found that a large portion of kids on Medicaid aren't getting their prescriptions filled. Report

Suggested Articles

AbbVie and Allergan were already jumping through hoops for their merger before a new tax added hundreds of millions to the cost.

Avastin and Herceptin saw U.S. slowdown that's “not very pronounced” after bioisim launched, but Roche execs still warn of "a significant impact.…

Novo Nordisk, which recently completed a wastewater treatment plant for its massive U.S. API site, has made a gift of the $40 million facility.